Results 11 to 20 of about 1,115 (179)

ECCO2R case study

open access: yesEgyptian Journal of Critical Care Medicine, 2018
Hypercapnic respiratory failure is common in ICU due to ARDS and COPD exacerbations. The use of ECCO2R has changed the way we manage these patients. We report a patient with COPD exacerbation that failed NIV and placed on low flow ECCO2R. Low flow ECCO2R
Marlice van Dyk
doaj   +4 more sources

Case Report: Extracorporeal Carbon Dioxide Removal in a Severely Brain-Injured Patient With Acute Respiratory Distress Syndrome [PDF]

open access: yesCase Reports in Critical Care
The management of acute respiratory distress syndrome (ARDS) in a patient suffering from a severe brain injury may be difficult, especially when hypercapnia occurs.
Sébastien Gibot   +2 more
doaj   +3 more sources

Lung- and diaphragm-protective strategies in acute respiratory failure: an in silico trial [PDF]

open access: yesIntensive Care Medicine Experimental
Background Lung- and diaphragm-protective (LDP) ventilation may prevent diaphragm atrophy and patient self-inflicted lung injury in acute respiratory failure, but feasibility is uncertain.
Damian Ratano   +6 more
doaj   +3 more sources

Intraoperative use of extracorporeal CO2 removal (ECCO2R) and emergency ECMO requirement in patients undergoing lung transplant: a case-matched cohort retrospective study [PDF]

open access: yesJournal of Anesthesia, Analgesia and Critical Care, 2022
Background The use of extracorporeal carbon dioxide removal (ECCO2R) is less invasive than extracorporeal membrane oxygenation (ECMO), and intraoperative control of gas exchange could be feasible.
Franco Ruberto   +9 more
doaj   +2 more sources

A randomised controlled trial of non-invasive ventilation compared with extracorporeal carbon dioxide removal for acute hypercapnic exacerbations of chronic obstructive pulmonary disease

open access: yesAnnals of Intensive Care, 2022
Background Patients presenting with acute hypercapnic respiratory failure due to exacerbations of chronic obstructive pulmonary disease (AECOPD) are typically managed with non-invasive ventilation (NIV).
Nicholas A. Barrett   +10 more
doaj   +2 more sources

“Awake” ECCO2R superseded intubation in a near-fatal asthma attack

open access: yesJournal of Intensive Care, 2017
Background Near-fatal asthma attacks are life threatening events that often require mechanical ventilation. Extracorporeal carbon dioxide removal (ECCO2R) is, beside extracorporeal membrane oxygenation (ECMO), a well-established rescue option whenever ...
Thomas-Michael Schneider   +2 more
doaj   +2 more sources

Treatment of Severe Hypercapnic Respiratory Failure Caused by SARS-CoV-2 Lung Injury with ECCO2R Using the Hemolung Respiratory Assist System

open access: yesCase Reports in Critical Care, 2021
Acute respiratory distress syndrome (ARDS) due to COVID-19 leads to a high rate of mortality in the intensive care unit (ICU). A lung-protective mechanical ventilation strategy using low tidal volumes is a cornerstone to management, but uncontrolled ...
Ramiro Saavedra-Romero   +6 more
doaj   +2 more sources

Low flow extracorporeal CO2 removal in ARDS patients: a prospective short-term crossover pilot study [PDF]

open access: yesBMC Anesthesiology, 2017
Background Lung protective mechanical ventilation (MV) is the corner stone of therapy for ARDS. However, its use may be limited by respiratory acidosis.
Harlinde Peperstraete   +5 more
doaj   +2 more sources

Daily use of extracorporeal CO2 removal in a critical care unit: indications and results

open access: yesJournal of Intensive Care, 2018
Background While outcome improvement with extracorporeal CO2 removal (ECCO2R) is not demonstrated, a strong pathophysiological rational supports its use in the setting of acute respiratory distress syndrome (ARDS) and COPD exacerbation.
Hadrien Winiszewski   +11 more
doaj   +2 more sources

A mock circulation loop to test extracorporeal CO2 elimination setups [PDF]

open access: yesIntensive Care Medicine Experimental, 2020
Background Extracorporeal carbon dioxide removal (ECCO2R) is a promising yet limited researched therapy for hypercapnic respiratory failure in acute respiratory distress syndrome and exacerbated chronic obstructive pulmonary disease.
Leonie S. Schwärzel   +9 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy